Skip to main content

Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C.

Publication ,  Journal Article
Binley, JM; Lybarger, EA; Crooks, ET; Seaman, MS; Gray, E; Davis, KL; Decker, JM; Wycuff, D; Harris, L; Hawkins, N; Wood, B; Nathe, C ...
Published in: J Virol
December 2008

Identifying the viral epitopes targeted by broad neutralizing antibodies (NAbs) that sometimes develop in human immunodeficiency virus type 1 (HIV-1)-infected subjects should assist in the design of vaccines to elicit similar responses. Here, we investigated the activities of a panel of 24 broadly neutralizing plasmas from subtype B- and C-infected donors using a series of complementary mapping methods, focusing mostly on JR-FL as a prototype subtype B primary isolate. Adsorption with gp120 immobilized on beads revealed that an often large but variable fraction of plasma neutralization was directed to gp120 and that in some cases, neutralization was largely mediated by CD4 binding site (CD4bs) Abs. The results of a native polyacrylamide gel electrophoresis assay using JR-FL trimers further suggested that half of the subtype B and a smaller fraction of subtype C plasmas contained a significant proportion of NAbs directed to the CD4bs. Anti-gp41 neutralizing activity was detected in several plasmas of both subtypes, but in all but one case, constituted only a minor fraction of the overall neutralization activity. Assessment of the activities of the subtype B plasmas against chimeric HIV-2 viruses bearing various fragments of the membrane proximal external region (MPER) of HIV-1 gp41 revealed mixed patterns, implying that MPER neutralization was not dominated by any single specificity akin to known MPER-specific monoclonal Abs. V3 and 2G12-like NAbs appeared to make little or no contribution to JR-FL neutralization titers. Overall, we observed significant titers of anti-CD4bs NAbs in several plasmas, but approximately two-thirds of the neutralizing activity remained undefined, suggesting the existence of NAbs with specificities unlike any characterized to date.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Virol

DOI

EISSN

1098-5514

Publication Date

December 2008

Volume

82

Issue

23

Start / End Page

11651 / 11668

Location

United States

Related Subject Headings

  • env Gene Products, Human Immunodeficiency Virus
  • Virology
  • Receptors, CCR5
  • Peptide Fragments
  • Neutralization Tests
  • Immunoglobulin G
  • Immunoglobulin A
  • Humans
  • HIV-1
  • HIV Envelope Protein gp41
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Binley, J. M., Lybarger, E. A., Crooks, E. T., Seaman, M. S., Gray, E., Davis, K. L., … Mascola, J. R. (2008). Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C. J Virol, 82(23), 11651–11668. https://doi.org/10.1128/JVI.01762-08
Binley, James M., Elizabeth A. Lybarger, Emma T. Crooks, Michael S. Seaman, Elin Gray, Katie L. Davis, Julie M. Decker, et al. “Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C.J Virol 82, no. 23 (December 2008): 11651–68. https://doi.org/10.1128/JVI.01762-08.
Binley, James M., et al. “Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C.J Virol, vol. 82, no. 23, Dec. 2008, pp. 11651–68. Pubmed, doi:10.1128/JVI.01762-08.
Binley JM, Lybarger EA, Crooks ET, Seaman MS, Gray E, Davis KL, Decker JM, Wycuff D, Harris L, Hawkins N, Wood B, Nathe C, Richman D, Tomaras GD, Bibollet-Ruche F, Robinson JE, Morris L, Shaw GM, Montefiori DC, Mascola JR. Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C. J Virol. 2008 Dec;82(23):11651–11668.

Published In

J Virol

DOI

EISSN

1098-5514

Publication Date

December 2008

Volume

82

Issue

23

Start / End Page

11651 / 11668

Location

United States

Related Subject Headings

  • env Gene Products, Human Immunodeficiency Virus
  • Virology
  • Receptors, CCR5
  • Peptide Fragments
  • Neutralization Tests
  • Immunoglobulin G
  • Immunoglobulin A
  • Humans
  • HIV-1
  • HIV Envelope Protein gp41